M+ cash runway to 2029, bitopertin FDA NDA/accelerated approval catalyst, and DISC-0974 myelofibrosis data—read now.

Alkermes (ALKS) shifts to fully integrated biopharma, leveraging Vibrance-2, Lybalvi growth, and Avadel buy to de-risk ...

Today, Overworld (formerly Wayfarer Labs) announced the release of a research preview of its local-first diffusion world model. This model is an early, experimental system targeted toward researchers, ...

TaylorMade’s Qi4D drivers break speed into four dimensions, pairing carbon faces, adjustable weighting and stock shafts built ...

We came across a bullish thesis on Recursion Pharmaceuticals, Inc. on r/stocks by Antique-Reference585. In this article, we ...

Beena Wood, Qinecsa, explains how AI could revolutionize pharmacovigilance, if data, trust, skills, and organizational ...

Toggle the Real-time protection switch off. You may receive a User Account Control (UAC) prompt asking if you want to allow the change to occur. Select Yes. When you're ready to turn system protection ...

New products expand Elo's front-of-house portfolio, helping retail, grocery, and hospitality businesses create intelligent operations ...

We came across a bullish thesis on United States Antimony Corporation on r/stocks by ICameSawAbstained. In this article, we will summarize the bulls’ thesis on UAMY.

Software offered more efficient processing of orders, nesting, machine programming, and scheduling, and the automation made ...

It's the first week of a new year and there's no time for the tech world to slowly ease back into things following the ...

A yearlong review and emotional testimony on hygiene, menstruation and supervision power imbalances frame the latest hearing.